Donna Abdelnour
Acute Care · Cincinnati, OHNPI 1811302698
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,281 of the $5,130 with a category attached, or 64.0%. 20 manufacturers reported payments, led by AbbVie at 58.1% of the total. Reporting peaked in 2024 at $2,858 and has fallen 83.4% since, to $473 in 2025. Among acute care clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 120 payments — averaging $42.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Gynesonics, Inc.$531
- Novo Nordisk$497
- Astellas Pharma US Inc$411
- Sumitomo Pharma America, Inc.$250
- Evofem Biosciences, Inc.$92
- plus $370 from 14 others
What the payments were for
- Speaking & faculty fees$1,50029%
- Travel & lodging$2144%
- Food & beverage$3,28164%
- Education$1353%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 36 | $2,978 |
| Gynesonics, Inc. | 5 | $531 |
| Novo Nordisk | 22 | $497 |
| Astellas Pharma US Inc | 12 | $411 |
| Sumitomo Pharma America, Inc. | 17 | $250 |
| Evofem Biosciences, Inc. | 5 | $92 |
| Mayne Pharma Commercial LLC | 3 | $49 |
| Lupin Inc. | 3 | $46 |
| Millicent US Inc | 2 | $44 |
| Therapeuticsmd, Inc. | 3 | $41 |
| Exact Sciences | 2 | $40 |
| Endo Pharmaceuticals Inc. | 2 | $34 |
| Lilly USA, LLC | 1 | $18 |
| Galderma Laboratories, L.p. | 1 | $18 |
| Exeltis, USA Inc. | 1 | $16 |
| Avion Pharmaceuticals | 1 | $16 |
| Ascend Therapeutics US, LLC | 1 | $13 |
| Organon | 1 | $12 |
| Hologic Sales And Service, LLC | 1 | $12 |
| Currax Pharmaceuticals LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,130 in reported general payments places this provider in the 95th percentile of 1,101 acute care providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IntrarosaPrasterone (Dhea) | 14 | $4,281 |
Paid to pharmacies, not to this prescriber.
Other acute care in Cincinnati
- Julie LurieCincinnati$13K
- Laura LangenhopCincinnati$8K
- Jennifer ClarkCincinnati$7K
- Amy HawkinsCincinnati$7K
- Rebecca BlantonCincinnati$6K
- Carrie MyersCincinnati$6K
- Kathleen RoederCincinnati$6K
- Nicole BrownCincinnati$5K
- Bonnie AlbertCincinnati$4K
- Jessica HendrixCincinnati$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.